NDC11 71104093301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71104-0933-01 | 71104-0933 |
| 71104-0933-1 | 71104-0933 |
| 71104-933-01 | 71104-933 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALPROLIX | COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN | Bioverativ Therapeutics Inc. | 2fb3fb92-379d-4683-80d6-b06c0a7dc063 | 2024-05-16 | Warnings, Adverse reactions | 71104-933-01 71104-933 71104093301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.